NEW YORK — A new neurology institute for the United States is set to open in Florida as part of the country’s efforts to address the nation’s long-standing neurological problems.
The newly opened New Neurologic Institute for Neuroethics and Social Responsibility is in the process of getting the go-ahead from the Florida Department of Health.
It is one of four centers being built by the New Neurological Institute, which is the brainchild of neuroscientist Michael B. Smith.
The others are in New Jersey and Pennsylvania.
“The New Neurologieis designed to help people understand the neurobiology of diseases like Alzheimer’s disease, traumatic brain injury, traumatic injuries and stroke,” the department said in a statement.
“We will provide research, education and clinical care to improve outcomes for people living with brain disorders.”
The New Neurogastory is a partnership between the New York State Medical Center, the Johns Hopkins University and the Florida State University School of Medicine.
The institute’s goal is to help improve the quality of care for people with neurodegenerative diseases, including Alzheimer’s, traumatic injury, trauma and stroke.
More than 300 people have enrolled in the New Neurodology Institute in the last two years.
According to the New Journal of Medicine, neurodegen- cies treatment is often considered “invasive” and not accessible to most Americans.
For instance, there are currently no neurodegeners-specific drugs available for treating ALS.
To date, the institute has been able to identify more than 1.2 million people with a history of neurological illness.
There is no cure for ALS, though scientists have identified a number of promising therapies.
If the new institute is approved, the state of Florida could be the first to offer neurodegening patients neuropathic pain treatments.